Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001628280-24-000469 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-04 | 2024-01-02 | BLFS | Berard Todd | CMO | S - Sale | $16.75 | -491 | 117.0K | -0.4% | -$8,224 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | S | D | 491 | $16.75 | 117,031 | D | — | — |